Published in Respirology on January 13, 2015
Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med (2008) 11.00
High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med (2013) 6.56
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum (2013) 5.99
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis (2013) 3.11
Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA (2007) 2.89
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med (2009) 2.77
Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ (2007) 2.33
Combining high-frequency oscillatory ventilation and recruitment maneuvers in adults with early acute respiratory distress syndrome: the Treatment with Oscillation and an Open Lung Strategy (TOOLS) Trial pilot study. Crit Care Med (2005) 1.81
A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation. Am J Respir Crit Care Med (2003) 1.69
Identifying motivations and barriers to patient participation in clinical trials. J Cancer Educ (2006) 1.61
Methods to elicit beliefs for Bayesian priors: a systematic review. J Clin Epidemiol (2009) 1.59
Effect of warfarin on survival in scleroderma-associated pulmonary arterial hypertension (SSc-PAH) and idiopathic PAH. Belief elicitation for Bayesian priors. J Rheumatol (2010) 1.58
High-frequency oscillation in adults: a utilization review. Crit Care Med (2011) 1.55
Using standardized family members to teach communication skills and ethical principles to critical care trainees. Crit Care Med (2012) 1.52
N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. Crit Care Med (2009) 1.51
Generalised muscle weakness in young adults with congenital heart disease. Heart (2011) 1.51
A new toolkit for conducting clinical trials in rare disorders. J Popul Ther Clin Pharmacol (2014) 1.47
Science review: Vasopressin and the cardiovascular system part 1--receptor physiology. Crit Care (2003) 1.43
Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol (2011) 1.40
The ICU outreach team. J Crit Care (2003) 1.39
Feasibility of blood conservation strategies in pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Interact Cardiovasc Thorac Surg (2011) 1.39
The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med (2009) 1.34
Impact of extracorporeal life support on outcome in patients with idiopathic pulmonary arterial hypertension awaiting lung transplantation. J Heart Lung Transplant (2011) 1.16
Complications from recruitment maneuvers in patients with acute lung injury: secondary analysis from the lung open ventilation study. Respir Care (2012) 1.16
Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. Respir Med (2010) 1.16
Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol (2003) 1.13
Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Chest (2006) 1.12
Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials. Am J Respir Crit Care Med (2014) 1.11
Office capillaroscopy in systemic sclerosis. Clin Rheumatol (2006) 1.11
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res (Hoboken) (2012) 1.06
Unsafe driving in North American automobile commercials. J Public Health (Oxf) (2005) 1.05
A valid and reliable belief elicitation method for Bayesian priors. J Clin Epidemiol (2009) 1.05
Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology. Crit Care (2003) 1.00
Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience. J Thorac Cardiovasc Surg (2012) 0.96
Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease. J Rheumatol (2012) 0.95
Biologic therapy for systemic sclerosis: a systematic review. J Rheumatol (2010) 0.93
Examining nursing vital signs documentation workflow: barriers and opportunities in general internal medicine units. J Clin Nurs (2012) 0.93
Magnetic resonance imaging of the hand in systemic sclerosis. J Rheumatol (2009) 0.88
Gene expression profiling in the lungs of patients with pulmonary hypertension associated with pulmonary fibrosis. Chest (2011) 0.88
N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. Can J Anaesth (2007) 0.87
Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety. J Rheumatol (2012) 0.87
Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis. Crit Care (2010) 0.86
Low bone density in systemic sclerosis. A systematic review. J Rheumatol (2013) 0.85
Haemodynamic and structural correlates of the first and second heart sounds in pulmonary arterial hypertension: an acoustic cardiography cohort study. BMJ Open (2013) 0.85
Ethnic influence on disease manifestations and autoantibodies in Chinese-descent patients with systemic sclerosis. J Rheumatol (2009) 0.84
Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension. J Rheumatol (2006) 0.84
Increased expression of nitric oxide synthase in human lung transplants after nitric oxide inhalation. Transplantation (2004) 0.83
Dysphagia and associated risk factors following extubation in cardiovascular surgical patients. Dysphagia (2014) 0.81
Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension. J Rheumatol (2008) 0.81
Critical care lessons from severe acute respiratory syndrome. Curr Opin Crit Care (2004) 0.81
Clinical evidence, practice guidelines, and β-blocker utilization before major noncardiac surgery. Circ Cardiovasc Qual Outcomes (2012) 0.81
Prophylaxis against venous thromboembolism in neurointensive care patients: survey of Canadian practice. J Crit Care (2009) 0.80
Selective serotonin reuptake inhibitors and pulmonary arterial hypertension: a case-control study. Chest (2011) 0.80
A review of the sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome. Where do the revised sapporo criteria add value? J Rheumatol (2007) 0.80
Elevated platelet angiostatin and circulating endothelial microfragments in idiopathic pulmonary arterial hypertension: a preliminary study. Thromb Res (2009) 0.79
Alternative designs for clinical trials in rare diseases. Am J Med Genet C Semin Med Genet (2016) 0.78
Pulmonary vasodilators--treating the right ventricle. Anesthesiol Clin (2008) 0.78
Right heart characteristics and exercise parameters in adults with Ebstein anomaly: new perspectives from cardiac magnetic resonance imaging studies. Int J Cardiol (2011) 0.78
Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis. Clin Exp Rheumatol (2012) 0.78
Cost-effectiveness of treprostinil versus epoprostenol in patients with pulmonary arterial hypertension: a Canadian analysis. Can Respir J (2005) 0.78
Survival after lung transplantation in systemic sclerosis. A systematic review. Respir Med (2013) 0.78
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: the Toronto experience. Can J Cardiol (2011) 0.78
Classification in systemic sclerosis. J Rheumatol (2006) 0.77
Development, sensibility, and reliability of the Toronto Axial Spondyloarthritis Questionnaire in inflammatory bowel disease. J Rheumatol (2013) 0.76
Evaluation of persistent pulmonary hypertension after acute pulmonary embolism. Chest (2007) 0.76
Surveys, samplings and botched US presidential election predictions. Eur J Anaesthesiol (2012) 0.76
An open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease. Can Respir J (2006) 0.76
Long-chain rhenium and technetium glucosamine conjugates. Dalton Trans (2009) 0.76
Dual therapy in IPAH and SSc-PAH. A qualitative systematic review. Respir Med (2012) 0.76
Disease modification and other trials in systemic sclerosis have come a long way, but have to go further. Arthritis Care Res (Hoboken) (2012) 0.75
Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension. Can Respir J (2014) 0.75
Bayesian inference: statistical gimmick or added value? J Rheumatol (2011) 0.75
Dramatic response to sirolimus in lymphangioleiomyomatosis. Can Respir J (2013) 0.75
Erectile dysfunction and scleroderma. J Rheumatol (2004) 0.75
Inflammatory arthritis, sacroiliitis, and morphea: evidence of a systemic inflammatory disease. Case Rep Rheumatol (2013) 0.75
Herod the Great and polyarteritis nodosa. Arch Intern Med (2004) 0.75
Inhaled nitric oxide for acute lung injury: no place for NO? JAMA (2004) 0.75
The effect of endogenous estrogen on Doppler-estimated right ventricular systolic pressure during exercise. Can J Physiol Pharmacol (2012) 0.75
ANCA-associated vasculitis in systemic sclerosis report of 3 cases. Rheumatol Int (2012) 0.75
Connect the dots: a rare case of spontaneous haemopneumothorax. Thorax (2013) 0.75
How Much Better Is Good Enough?: Patient-reported Outcomes, Minimal Clinically Important Differences, and Patient Acceptable Symptom States in Perioperative Research. Anesthesiology (2016) 0.75
Gastric antral vascular ectasia unmasked by alprostadil for digital ulceration in scleroderma. J Rheumatol (2011) 0.75